ÂÜÀòÂÒÂ×

Ronald Smulders is a seasoned professional in analytical development and quality control, currently serving as Senior Director at Byondis since September 2016, where responsibilities include managing a department of approximately 80 staff and overseeing the analytical development of innovative complex protein products, including method development and validation. Prior to Byondis, Ronald held various roles at Merck, rising from Director to Executive Director, managing substantial teams and focusing on late-stage analytical development of recombinant protein products. Earlier career experiences include leadership positions at Schering-Plough Research Institute and Organon, where Ronald managed departments and sections responsible for both early and late-stage development of sterile drug products. Ronald earned a PhD in Biochemistry from Radboud University in 1997.